In The News Posted February 22, 2019 Share Posted February 22, 2019 NORTH CHICAGO, Ill. and CAMBRIDGE, Mass., Feb. 22, 2019 /PRNewswire/ -- AbbVie (NYSE: ABBV), a global biopharmaceutical company, and Voyager Therapeutics, Inc. (Nasdaq: VYGR), a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological... View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.